Compare Amphastar Pharmaceuticals Inc (AMPH) vs Star Bulk Carriers Corp (SBLK) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs Star Bulk Carriers Corp — how do they compare? Amphastar Pharmaceuticals Inc trades at $18.72 (market cap $826.08M), while Star Bulk Carriers Corp trades at $25.69 (market cap $2.94B). The key difference: Star Bulk Carriers Corp is far larger — about 3.6× Amphastar Pharmaceuticals Inc's market cap, and Star Bulk Carriers Corp pays a 3.91% dividend while Amphastar Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMPH | SBLK | |
|---|---|---|
Market Cap | $826.08M | $2.94B |
Sector | Health | Industrials |
52-Week High | $30.81 | $28.21 |
52-Week Low | $16.87 | $16.79 |
Enterprise Value | $1.22B | $3.64B |
Dividend Yield | — | 3.91% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.
The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.
Star Bulk Carriers (SBLK) trades at $26.35, up 1.82% today, with a neutral technical signal and bullish moving averages. The company reported strong Q1 2026 earnings of $0.56 per share, beating estimates, and maintains a dividend payout. Revenue grew to $1.1 billion in 2026, with net income margin improving to 13.01%. Analyst consensus is bullish with 14 buy ratings.
SBLK presents a positive outlook with earnings beats and dividend returns, but faces risks from dry bulk market volatility and economic cycles. The stock's valuation at a P/E of 21.08 is reasonable given growth, yet investor caution is warranted on global trade fluctuations impacting shipping demand.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About Star Bulk Carriers Corp
Star Bulk Carriers Corp. is a global shipping company specializing in the seaborne transportation of dry bulk commodities. The company owns and operates a large fleet of bulk carriers, primarily transporting major commodities such as iron ore, coal, and grain. SBLK focuses on the Capesize, Post Panamax, and Kamsarmax vessel segments, providing critical logistical services to commodity producers and consumers worldwide.
Read more on SBLK →
